Crossmark Global Holdings Inc. reduced its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 3.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 29,445 shares of the medical instruments supplier’s stock after selling 940 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in DENTSPLY SIRONA were worth $1,938,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Massey Quick Simon & CO. LLC purchased a new stake in shares of DENTSPLY SIRONA during the third quarter valued at $124,000. Huntington National Bank purchased a new stake in shares of DENTSPLY SIRONA during the third quarter valued at $157,000. First Interstate Bank purchased a new stake in shares of DENTSPLY SIRONA during the third quarter valued at $164,000. Stock Yards Bank & Trust Co. purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at $203,000. Finally, Dupont Capital Management Corp boosted its stake in shares of DENTSPLY SIRONA by 85.0% during the fourth quarter. Dupont Capital Management Corp now owns 3,308 shares of the medical instruments supplier’s stock valued at $218,000 after purchasing an additional 1,520 shares during the period. 96.51% of the stock is owned by hedge funds and other institutional investors.

A number of brokerages have recently issued reports on XRAY. HC Wainwright lowered shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and set a $68.00 target price for the company. in a research note on Thursday, November 30th. Deutsche Bank began coverage on shares of DENTSPLY SIRONA in a research note on Friday, December 8th. They set a “buy” rating and a $81.00 target price for the company. BidaskClub lowered shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Tuesday, January 23rd. Barrington Research raised shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 target price for the company in a research note on Monday, November 6th. Finally, Zacks Investment Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, January 8th. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $69.15.

Shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) opened at $57.38 on Tuesday. DENTSPLY SIRONA Inc has a one year low of $52.53 and a one year high of $68.98. The firm has a market cap of $13,250.00, a PE ratio of -16.49, a P/E/G ratio of 2.11 and a beta of 1.17. The company has a quick ratio of 1.59, a current ratio of 2.32 and a debt-to-equity ratio of 0.21.

In related news, Director Eric Brandt sold 6,409 shares of the company’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $68.04, for a total value of $436,068.36. Following the completion of the sale, the director now directly owns 12,073 shares of the company’s stock, valued at $821,446.92. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.99% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION WARNING: “DENTSPLY SIRONA Inc (XRAY) Stake Lessened by Crossmark Global Holdings Inc.” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The legal version of this news story can be read at https://www.thecerbatgem.com/2018/02/13/dentsply-sirona-inc-xray-stake-lessened-by-crossmark-global-holdings-inc.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.